Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) Profit After Tax (2016 - 2025)

Sanara MedTech's Profit After Tax history spans 15 years, with the latest figure at $35.6 million for Q4 2025.

  • For Q4 2025, Profit After Tax rose 474.62% year-over-year to $35.6 million; the TTM value through Dec 2025 reached -$397366.0, down 158.47%, while the annual FY2025 figure was -$393124.0, 79.71% up from the prior year.
  • Profit After Tax reached $35.6 million in Q4 2025 per SMTI's latest filing, up from -$30.4 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $35.6 million in Q4 2025 to a low of -$30.4 million in Q3 2025.
  • Average Profit After Tax over 5 years is -$1.0 million, with a median of -$1.6 million recorded in 2022.
  • Peak YoY movement for Profit After Tax: skyrocketed 1755.09% in 2024, then plummeted 16749.4% in 2025.
  • A 5-year view of Profit After Tax shows it stood at -$3.5 million in 2021, then dropped by 17.86% to -$4.1 million in 2022, then surged by 90.9% to -$373899.0 in 2023, then surged by 1755.09% to $6.2 million in 2024, then skyrocketed by 474.62% to $35.6 million in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Profit After Tax are $35.6 million (Q4 2025), -$30.4 million (Q3 2025), and -$2.0 million (Q2 2025).